FindTrial
Sign In

A study of usefulness of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the initial staging and assessment of response to treatment in locally advanced breast cancer

A prospective study of utility of [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the initial staging and response assessment of locally advanced breast cancer patients receiving neoadjuvant chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013455
Enrollment
100
Registered
2018-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with locally advanced breast cancer

Interventions

Intervention1: PET/CT: Whole body 18FDG PET/CT

Sponsors

Sri Venkateswara Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: biopsy proven locally advanced breast cancer women

Exclusion criteria

Exclusion criteria: Patients with early breast cancer or found to have metastatic disease on conventional imaging will be excluded from the study. Patients who have already received treatment elsewhere will be excluded. Male patients with breast cancer will not be included.

Design outcomes

Primary

MeasureTime frame
1. To evaluate the utility of FDG PET/CT in initial staging of locally advanced breast cancer. 2. To compare FDG PET/CT with conventional methods in staging of locally advanced breast cancer 3. To evaluate the role of FDG PET/CT in predicting pathological response to neoadjuvant chemotherapy in comparison to other methods 4. Usefulness of PET/CTin selection of patients for breast conservation surgery vs mastectomy after NACT Timepoint: February 2015—

Secondary

MeasureTime frame
Usefulness of PET/CTin selection of patients for breast conservation surgery vs mastectomy after NACT Timepoint: over 20 month period—

Countries

India

Contacts

Public ContactSivanath Reddy Gajjala

Sri Venakteswara Institute of Medical Sciences Tirupati

drnarendrah@yahoo.co.in917382629699

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026